Smoldering myeloma
Item
1. patients fulfilling the criteria of smm. (see appendix i)
boolean
C1531608 (UMLS CUI [1])
Smoldering myeloma Progressive
Item
2. patients with progressive smoldering myeloma. (see appendix ii)
boolean
C1531608 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
Age
Item
3. age 18-80 years.
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
4. signed informed consent prior to patient recruitment.
boolean
C0021430 (UMLS CUI [1])
Multiple Myeloma
Item
1. patients fulfilling diagnostic criteria of active mm .(see appendix i)
boolean
C0026764 (UMLS CUI [1])
Plasmacytoma | Non-secretory myeloma | Myeloma M Protein Very low | Light chain myeloma
Item
2. patients fulfilling diagnostic criteria of: solitary myeloma or non secreting myeloma or oligosecretory myeloma or light chain myeloma.
boolean
C0032131 (UMLS CUI [1])
C0456845 (UMLS CUI [2])
C0026764 (UMLS CUI [3,1])
C0700271 (UMLS CUI [3,2])
C0442811 (UMLS CUI [3,3])
C0456844 (UMLS CUI [4])
Statins
Item
3. patients on statin treatment on the day of recruitment.
boolean
C0360714 (UMLS CUI [1])
Chemotherapy | Steroids
Item
4. patients on chemotherapy or receiving steroids.
boolean
C0392920 (UMLS CUI [1])
C0038317 (UMLS CUI [2])
Medical contraindication Statins
Item
5. patients with any contraindication to statin treatment:
boolean
C1301624 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
Intolerance to Statins | Statin allergy
Item
known intolerance or hypersensitivity to statin.
boolean
C1744706 (UMLS CUI [1,1])
C0360714 (UMLS CUI [1,2])
C0571873 (UMLS CUI [2])
Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
sgot or sgpt above 1.5 times of upper normal level (unl).
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
Creatine phosphokinase serum increased
Item
cpk above unl
boolean
C0241005 (UMLS CUI [1])
Macrolides | Antifungal Agents | Ketoconazole
Item
concomitant treatment with macrolides and or antifungal agents (ketoconazole)
boolean
C0282563 (UMLS CUI [1])
C0003308 (UMLS CUI [2])
C0022625 (UMLS CUI [3])
Creatinine measurement, serum
Item
creatinine level above 1.5 mg%
boolean
C0201976 (UMLS CUI [1])
Disease Severe | Disease Uncontrolled | Diabetic - poor control | Chronic Kidney Diseases | Communicable Disease Uncontrolled
Item
any severe and/or uncontrolled medical disease (i.e., uncontrolled diabetes, chronic renal disease, or active uncontrolled infection).
boolean
C0012634 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0421258 (UMLS CUI [3])
C1561643 (UMLS CUI [4])
C0009450 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
Second Primary Cancers | Exception Skin carcinoma | Exception Disease Free of
Item
6. patients with second primary malignancy (except for non melanoma skin malignancy) unless they have been disease free for at least five years.
boolean
C0751623 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0332296 (UMLS CUI [3,3])
Substance Use Disorders
Item
7. patients who have a history of alcohol or drug abuse.
boolean
C0038586 (UMLS CUI [1])
Protocol Compliance Unable
Item
8. patients who are mentally or physically unable to comply with all aspects of the study.
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Study Subject Participation Status | Investigational New Drugs
Item
9. participation to an investigational drug trial
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])